Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023

Rhea-AI Summary

Horizon Therapeutics plc (NASDAQ: HZNP) will release its fourth-quarter and full-year 2022 financial results on March 1, 2023, before U.S. markets open. This announcement follows the company's recent acquisition agreement with Amgen. Due to this acquisition, Horizon will not hold a conference call to discuss the financial results. Investors can access the earnings release on the Investor Relations page of Horizon's website. Horizon focuses on developing therapies for rare and autoimmune diseases, emphasizing their commitment to delivering meaningful treatments to patients in need.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2022 financial results on Wednesday, March 1, 2023, prior to the open of U.S. financial markets.

In light of the recently announced agreement to be acquired by Amgen Inc. and applicable securities laws, Horizon will not be hosting a conference call to discuss its financial results. The earnings press release will be made available publicly on the Investor Relations page of its website at https://ir.horizontherapeutics.com.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230130005183/en/

Investor Relations:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

Investor-relations@horizontherapeutics.com

U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communication Officer

media@horizontherapeutics.com

Ireland Media:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics announce its Q4 and full-year 2022 financial results?

Horizon Therapeutics will announce its Q4 and full-year 2022 financial results on March 1, 2023.

Will Horizon Therapeutics host a conference call for its financial results?

No, Horizon will not host a conference call due to its acquisition agreement with Amgen.

Where can I find Horizon Therapeutics' financial results?

The financial results can be found on the Investor Relations page of Horizon's website.

What is the significance of Horizon's acquisition by Amgen?

The acquisition by Amgen impacts Horizon's operational strategies, including changes in how financial results are communicated.